MCID: TRN018
MIFTS: 63

Transitional Cell Carcinoma malady

Rare diseases, Cancer diseases, Nephrological diseases categories

Summaries for Transitional Cell Carcinoma

About this section
Sources:
9Disease Ontology, 66Wikipedia, 34MalaCards
See all sources

Fully expand this MalaCard

Download this MalaCard
Wikipedia:66 Transitional cell carcinoma (TCC, also urothelial cell carcinoma or UCC) is a type of cancer that... more...

MalaCards: Transitional Cell Carcinoma, also known as transitional cell neoplasm, is related to bladder transitional cell carcinoma and inverted papilloma. An important gene associated with Transitional Cell Carcinoma is ERBB2 (v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2), and among its related pathways are Transcriptional activation of cell cycle inhibitor p21 and GADD45 Pathway. The compounds topotecan and temozolomide have been mentioned in the context of this disorder. Affiliated tissues include kidney, prostate and ovary, and related mouse phenotypes are pigmentation and hearing/vestibular/ear.

Disease Ontology:9 A carcinoma that derives from transitional epithelial cells.

Aliases & Classifications for Transitional Cell Carcinoma

About this section
Sources:
9Disease Ontology, 44NIH Rare Diseases, 11DISEASES, 63UMLS, 46Novoseek, 41NCIt, 59SNOMED-CT, 36MeSH
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Rare diseases, Cancer diseases
Anatomical: Nephrological diseases


Aliases & Descriptions:

transitional cell carcinoma 9 44 11
transitional cell neoplasm 9 63
transitional cell carcinoma of the urinary tract 9
transitional cell carcinoma nos 9
carcinoma, transitional cell 63
carcinoma transitional cell 46
urothelial cell carcinoma 9
transitional cell tumor 9
transitional carcinoma 9


External Ids:

Disease Ontology9 DOID:2671
NCIt41 C4030, C2930
MeSH36 D002295

Related Diseases for Transitional Cell Carcinoma

About this section
Sources:
18GeneCards, 19GeneDecks
See all sources

Diseases related to Transitional Cell Carcinoma via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 184)
idRelated DiseaseScoreTop Affiliating Genes
1bladder transitional cell carcinoma31.9TP53, IFI27
2inverted papilloma31.0IFI27, KRT13
3papilloma31.0TP53, IFI27, KRT13, CDKN1A
4bladder carcinoma30.6CGB, CDKN1A, ERBB2, TP53
5adenocarcinoma30.6IFI27, PRSS8, MMP10, TP53, ERBB2, KRT13
6osteosarcoma30.4CGB, CDKN1A, NOTCH1, TP53
7adenoma30.3TP53, IFI27, NR2F1, KRT13, CDKN1A, CGB
8lung cancer30.2TP53, ERBB2, CDKN1A, EGFR
9colon cancer30.1FGF3, EGFR, CDKN1A, TP53
10endometrial carcinoma30.1TP53, IFI27, ERBB2, EGFR, FGF3
11retinoblastoma30.1TP53, IFI27, ERBB2, CDKN1A, EGFR, FGF3
12melanoma30.1TP53, IFI27, NOTCH1, CDKN1A, CGB, FGF3
13prostate cancer30.0PRSS8, IFI27, ERBB2, CDKN1A, EGFR, CGB
14prostatitis10.8
15invasive bladder transitional cell carcinoma10.6
16sarcomatoid transitional cell carcinoma10.6
17endotheliitis10.5
18urethritis10.5
19prostate transitional cell carcinoma10.5
20ovary transitional cell carcinoma10.5
21renal cell carcinoma10.5
22renal pelvis transitional cell carcinoma10.4
23horseshoe kidney10.4
24collecting duct carcinoma10.4
25ureter transitional cell carcinoma10.4
26urachal cyst10.4
27transitional cell carcinoma of the corpus uteri10.4
28kidney pelvis sarcomatoid transitional cell carcinoma10.3
29urethral diverticulum10.3
30urethra transitional cell carcinoma10.3
31papillary transitional carcinoma10.3
32endometrial transitional cell carcinoma10.3
33fallopian tube transitional cell carcinoma10.3
34ureterocele10.3
35hydronephrosis10.3
36bartholin's gland transitional cell carcinoma10.3
37prostate adenocarcinoma10.3
38urinary tract non-invasive transitional cell neoplasm10.2
39bladder papillary transitional cell neoplasm10.2
40nephrogenic adenoma10.2
41ovarian brenner tumor10.2
42infiltrating ureter transitional cell carcinoma10.2
43neuronitis10.2
44hypercalcemia10.2
45leukemoid reaction10.2
46acanthosis nigricans10.2
47xanthogranulomatous pyelonephritis10.2
48lambert-eaton myasthenic syndrome10.2
49clear cell adenocarcinoma10.2
50cerebritis10.2

Graphical network of the top 20 diseases related to Transitional Cell Carcinoma:



Diseases related to transitional cell carcinoma

Symptoms for Transitional Cell Carcinoma

About this section

Drugs & Therapeutics for Transitional Cell Carcinoma

About this section
Sources:
6CenterWatch, 43NIH Clinical Center, 7ClinicalTrials, 63UMLS, 42NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Transitional Cell Carcinoma

Drug clinical trials:

Search ClinicalTrials for Transitional Cell Carcinoma

Search NIH Clinical Center for Transitional Cell Carcinoma

Search CenterWatch for Transitional Cell Carcinoma

Genetic Tests for Transitional Cell Carcinoma

About this section

Anatomical Context for Transitional Cell Carcinoma

About this section
Sources:
34MalaCards
See all sources

MalaCards organs/tissues related to Transitional Cell Carcinoma:

34
Kidney, Prostate, Ovary, Lymph node, Endothelial, Lung, Testes, Cervix, Bone, Brain, Testis, Breast, Adipocyte, Monocytes, Colon, Heart, Bone marrow, Spinal cord, Dentritic cells

Animal Models for Transitional Cell Carcinoma or affiliated genes

About this section
Sources:
38MGI
See all sources

Publications for Transitional Cell Carcinoma

About this section
Sources:
53PubMed
See all sources

Articles related to Transitional Cell Carcinoma:

(show top 50)    (show all 1057)
idTitleAuthorsYear
1
Recurrent transitional cell carcinoma of the bladder: A mixed nested variant case report and literature review. (22511434)
2012
2
Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review. (22759317)
2012
3
Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor. (23018212)
2012
4
Prognostic significance of P27 (Kip 1) and MUC1 in papillary transitional cell carcinoma of the urinary bladder. (21346826)
2011
5
Ureterectomy and ureteral reimplatation for low-grade transitional cell carcinoma: is the laparoscopic approach feasible and effective? (21826883)
2011
6
Transitional cell carcinoma of the native urinary tract after kidney transplantation: recommendations following a long-term retrospective analysis. (21412138)
2011
7
Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17. (19443884)
2009
8
Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter. (19190765)
2009
9
Gemcitabine, paclitaxel, and cisplatin as combined adjuvant approach in transitional cell carcinoma of the urothelium. (19773726)
2009
10
Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. (19033864)
2009
11
Transitional cell carcinoma in renal transplant recipients: a single center experience. (18184173)
2008
12
Transitional cell carcinoma of the urinary bladder: a clinicopathological study. (18946612)
2008
13
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207. (18272914)
2008
14
Upper urinary tract transitional cell carcinoma. A 10-year experience. (18468339)
2008
15
Adenoviral receptor expression of normal bladder and transitional cell carcinoma of the bladder. (17293658)
2007
16
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group. (17011058)
2006
17
Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography. (15989448)
2005
18
Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. (16361539)
2005
19
A case of transitional cell carcinoma of the renal pelvis with adenocarcinoma producing CEA and CA19-9]. (15518131)
2004
20
Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma. (15450303)
2004
21
Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder. (14685796)
2004
22
Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas. (14981907)
2003
23
Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome. (12796695)
2003
24
Docetaxel enhances the therapeutic effect of the angiogenesis inhibitor TNP-470 (AGM-1470) in metastatic human transitional cell carcinoma. (12576464)
2003
25
Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder. (11834417)
2002
26
p53 and bcl-2 overexpression as associated risk factors in patients 40 years old or less with transitional cell carcinoma of the bladder. (11464113)
2001
27
Urinary cytokeratin 20 as a marker for transitional cell carcinoma. (10765100)
2000
28
Correlative expression of glutathione S-transferase-pi and multidrug resistance associated protein in bladder transitional cell carcinoma. (12840920)
2000
29
Screening for transitional cell carcinoma of the bladder with trophoblastic differentiation in Upper Galilee]. (10909500)
1998
30
Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma. (9818021)
1998
31
Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2. (9477105)
1998
32
Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma. (10210109)
1998
33
Correlation of nuclear morphometry and immunostaining for p53 and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder. (9477184)
1997
34
Flow cytometric evaluation of transferrin receptor in transitional cell carcinoma. (9373912)
1997
35
A hot spot for p53 mutation in transitional cell carcinoma of the bladder: clues to the etiology of bladder cancer. (9264274)
1997
36
Results at 43 months' follow-up of a double-blind, randomized, prospective clinical trial using intravesical interferon alpha-2b in the prophylaxis of stage pT1 transitional cell carcinoma of the bladder. (9037279)
1997
37
Detection and clinical pathological significance of the expression of P21, P185, p53 proteins and mutation of ras, p53 genes in transitional cell carcinoma of the bladder]. (9275651)
1996
38
Expression of CD44 splice variants in human transitional cell carcinoma. (8740026)
1996
39
Overexpression of C-erbB3 in transitional cell carcinoma of the ovary]. (8745489)
1995
40
Transitional cell carcinoma of the renal pelvis with choriocarcinomatous differentiation. Immunohistochemical and immunoelectron microscopic assessment of human chorionic gonadotropin production by transitional cell carcinoma of the urinary bladder. (8448745)
1993
41
The rat bladder tumor model system RBT resembles phenotypically and cytogenetically human superficial transitional cell carcinoma. (8171764)
1993
42
Cytokine-induced gene expression of interleukin-8 in human transitional cell carcinomas and renal cell carcinomas. (1739130)
1992
43
Primary localized amyloidosis of the renal pelvis coexisting with transitional cell carcinoma: a case report. (1632328)
1992
44
c-erbB-2 (HER-2/neu) oncopeptide immunoreactivity in localized, high-grade transitional cell carcinoma of the bladder. (1364264)
1992
45
Transitional cell carcinoma in a urethral diverticulum. (1586346)
1992
46
Epidermal nevus with transitional cell carcinomas of the urinary tract. (1802914)
1991
47
Renal transitional cell carcinoma mimicking medullary sponge kidney. (2021801)
1991
48
ABO(H) antigens and beta-2 microglobulin in transitional cell carcinoma. Predictors of response to intravesical bacillus Calmette-Guerin. (1710534)
1991
49
Correlation of the expression of A, B isoantigens with its precursor H antigen in transitional cell carcinoma and the clinical signification of the expression]. (2086062)
1990
50
Nephrogenic adenoma in patients with transitional cell carcinoma of the bladder receiving intravesical thiotepa. (3121867)
1988

Variations for Transitional Cell Carcinoma

About this section

Expression for genes affiliated with Transitional Cell Carcinoma

About this section
Sources:
2BioGPS, 16Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Transitional Cell Carcinoma

Search GEO for disease gene expression data for Transitional Cell Carcinoma.

Pathways for genes affiliated with Transitional Cell Carcinoma

About this section
Sources:
51PathCards, 56Reactome, 54QIAGEN, 39NCBI BioSystems Database, 31KEGG, 61Thomson Reuters, 58SinoBiological, 62Tocris Bioscience, 52PharmGKB, 55R&D Systems
See all sources

Pathways related to Transitional Cell Carcinoma according to GeneCards/GeneDecks:

(show all 44)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
10.0CDKN1A, TP53
210.0CDKN1A, TP53
3
Show member pathways
10.0CDKN1A, TP53
410.0EGFR, ERBB2
5
Show member pathways
AhR pathway39
10.0EGFR, CDKN1A
610.0EGFR, NOTCH1
7
Show member pathways
DNA damage response (only ATM dependent)39
Wnt Signaling Pathway and Pluripotency39
9.8CDKN1A, ERBB2, TP53
8
Show member pathways
Development EGFR signaling via PIP361
Development PDGF signaling via MAPK cascades61
Apoptosis and survival Anti apoptotic action of membrane bound ESR161
Signaling of Hepatocyte Growth Factor Receptor39
Development EGFR signaling via small GTPases61
Development Neurotrophin family signaling61
Apoptosis and survival NGF signaling pathway61
Apoptosis and survival Role of CDK5 in neuronal death and survival61
9.8TP53, ERBB2, EGFR
99.8EGFR, ERBB2, TP53
10
Show member pathways
9.8TP53, ERBB2, EGFR
11
Show member pathways
9.8TP53, ERBB2, EGFR
12
Show member pathways
Translation Non genomic rapid action of Androgen Receptor61
9.8EGFR, CDKN1A, ERBB2
13
Show member pathways
9.8ERBB2, CDKN1A, EGFR
149.8EGFR, CDKN1A, TP53
159.8EGFR, CDKN1A, TP53
169.8TP53, CDKN1A, EGFR
179.8TP53, CDKN1A, EGFR
189.7RBX1, TP53
19
Show member pathways
9.6EGFR, CDKN1A, ERBB2, TP53
20
Show member pathways
ErbB receptor signaling network39
ErbB signaling pathway39
9.6EGFR, CDKN1A, ERBB2, TP53
219.6TP53, ERBB2, CDKN1A, EGFR
22
Show member pathways
Signal transduction PTEN pathway61
9.6TP53, ERBB2, CDKN1A, EGFR
239.6TP53, ERBB2, CDKN1A, EGFR
249.5TP53, RBX1, CDKN1A
25
Show member pathways
Cell cycle39
9.5TP53, RBX1, CDKN1A
26
Show member pathways
9.5TP53, ERBB2, EGFR, FGF3
27
Show member pathways
9.5FGF3, EGFR, CDKN1A, ERBB2
28
Show member pathways
9.5ERBB2, CDKN1A, EGFR, FGF3
29
Show member pathways
9.5ERBB2, CDKN1A, EGFR, FGF3
309.5TP53, CDKN1A, EGFR, FGF3
31
Show member pathways
9.5RBX1, NOTCH1, TP53
329.3TP53, ERBB2, NOTCH1, CDKN1A, EGFR
33
Show member pathways
9.3TP53, ERBB2, NOTCH1, CDKN1A, EGFR
34
Show member pathways
Signaling Pathways in Glioblastoma39
9.3TP53, ERBB2, CDKN1A, EGFR, FGF3
359.3FGF3, EGFR, CDKN1A, ERBB2, TP53
369.3ERBB2, RBX1, CDKN1A, EGFR
37
Show member pathways
Delta-Notch Signaling Pathway39
Notch Signaling Pathway39
9.2TP53, NOTCH1, RBX1, EGFR
38
Show member pathways
9.0FGF3, EGFR, RBX1, ERBB2, TP53
39
Show member pathways
9.0FGF3, EGFR, CDKN1A, RBX1, ERBB2
40
Show member pathways
9.0ERBB2, RBX1, CDKN1A, EGFR, FGF3
418.8FGF3, EGFR, CDKN1A, RBX1, ERBB2, TP53
428.7ERBB2, NOTCH1, RBX1, CDKN1A, EGFR, FGF3
43
Show member pathways
8.6TP53, MMP10, ERBB2, NOTCH1, CDKN1A, EGFR
44
Show member pathways
8.5TP53, ERBB2, NOTCH1, RBX1, CDKN1A, EGFR

Compounds for genes affiliated with Transitional Cell Carcinoma

About this section
Sources:
46Novoseek, 12DrugBank, 62Tocris Bioscience, 52PharmGKB, 25HMDB, 30IUPHAR, 3BitterDB
See all sources

Compounds related to Transitional Cell Carcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 98)
idCompoundScoreTop Affiliating Genes
1topotecan46 1211.5EGFR
2temozolomide46 1211.4CDKN1A, TP53
3hrgbeta14610.2EGFR, CDKN1A, ERBB2
4optimax4610.1CDKN1A, IFI27
5p000484610.1CDKN1A, IFI27
6n-(4-hydroxyphenyl)retinamide4610.1CDKN1A, ERBB2, TP53
7jnj 28871063 hydrochloride6210.0EGFR, ERBB2
8pd1587804610.0ERBB2, EGFR
9taxane4610.0TP53, ERBB2, CDKN1A, EGFR
10suberoylanilide hydroxamic acid4610.0TP53, ERBB2, CDKN1A, EGFR
11oxaliplatin46 52 1212.0EGFR, CDKN1A, ERBB2, TP53
12flavopiridol46 1211.0TP53, ERBB2, CDKN1A, EGFR
13bortezomib46 52 1212.0EGFR, CDKN1A, ERBB2, TP53
14irinotecan46 52 1212.0EGFR, CDKN1A, ERBB2, TP53
15leucovorin46 52 1212.0ERBB2, EGFR, CGB
16geldanamycin46 52 62 1213.0TP53, ERBB2, CDKN1A, EGFR
17gemcitabine46 52 1212.0EGFR, CDKN1A, ERBB2, TP53
18hmba469.9CDKN1A, IFI27, TP53
19ag 490629.9ERBB2, EGFR
20docetaxel46 52 62 1212.9TP53, ERBB2, CDKN1A, EGFR
21batimastat46 62 1211.9MMP10, ERBB2, EGFR
22egcg469.9TP53, ERBB2, CDKN1A, EGFR
23curcumin469.9TP53, ERBB2, CDKN1A, EGFR
24indole-3-carbinol469.9TP53, IFI27, CDKN1A
25sulindac46 1210.9CDKN1A, IFI27, TP53
265fluorouracil469.8EGFR, CDKN1A, ERBB2, TP53
27roscovitine469.7TP53, IFI27, CDKN1A
28gefitinib46 52 1211.7IFI27, ERBB2, CDKN1A, EGFR
29iressa629.7ERBB2, EGFR
30resveratrol46 62 25 1212.7TP53, IFI27, ERBB2, CDKN1A
31adpribose469.7EGFR, CDKN1A, IFI27, TP53
32mg 13246 6210.7EGFR, CDKN1A, IFI27, TP53
33agar469.6FGF3, EGFR, CDKN1A, ERBB2
34thymidylate469.6TP53, IFI27, ERBB2, CDKN1A, EGFR
35n acetylcysteine469.5TP53, IFI27, ERBB2, CDKN1A, EGFR
36tamoxifen46 52 30 1212.5TP53, IFI27, ERBB2, CDKN1A, EGFR
37paclitaxel46 52 1211.5TP53, IFI27, ERBB2, CDKN1A, EGFR
38rapamycin469.5IFI27, ERBB2, NOTCH1, CDKN1A, EGFR
39genistein46 30 62 3 25 1214.4IFI27, ERBB2, NOTCH1, CDKN1A, EGFR
40retinoid469.4TP53, IFI27, CDKN1A, EGFR
41ly294002469.3TP53, IFI27, ERBB2, NOTCH1, CDKN1A, EGFR
42doxorubicin46 52 1211.3TP53, IFI27, ERBB2, NOTCH1, CDKN1A, EGFR
43cisplatin46 52 62 1212.2TP53, IFI27, ERBB2, CDKN1A, EGFR, CGB
44paraffin469.1TP53, IFI27, ERBB2, KRT13, CDKN1A, EGFR
45progesterone46 30 62 25 1213.0TP53, IFI27, NR2F1, ERBB2, CDKN1A, EGFR
46serine468.7TP53, MMP10, PRSS8, ERBB2, NOTCH1, CDKN1A
47estrogen468.7TP53, IFI27, NR2F1, ERBB2, NOTCH1, CDKN1A
48vegf468.4FGF3, TP53, MMP10, IFI27, ERBB2, NOTCH1
49oligonucleotide468.2MZF1, TP53, MMP10, IFI27, NR2F1, CDKN1A
50retinoic acid46 259.0MZF1, TP53, IFI27, NR2F1, KRT13, NOTCH1

GO Terms for genes affiliated with Transitional Cell Carcinoma

About this section
Sources:
17Gene Ontology
See all sources

Cellular components related to Transitional Cell Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1receptor complexGO:0432359.5EGFR, NOTCH1, ERBB2
2nucleoplasmGO:0056548.9CDKN1A, RBX1, NOTCH1, NR2F1, TP53

Biological processes related to Transitional Cell Carcinoma according to GeneCards/GeneDecks:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1mitotic cell cycle arrestGO:07185010.2CDKN1A, TP53
2intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorGO:04277110.0CDKN1A, TP53
3positive regulation of epithelial cell proliferationGO:05067910.0EGFR, NOTCH1, ERBB2
4cellular response to ionizing radiationGO:0714799.9CDKN1A, TP53
5cell cycle arrestGO:0070509.8CDKN1A, HEPACAM, TP53
6phosphatidylinositol-mediated signalingGO:0480159.8FGF3, EGFR, CDKN1A, ERBB2
7fibroblast growth factor receptor signaling pathwayGO:0085439.7ERBB2, CDKN1A, EGFR, FGF3
8Fc-epsilon receptor signaling pathwayGO:0380959.7ERBB2, CDKN1A, EGFR, FGF3
9positive regulation of reactive oxygen species metabolic processGO:20003799.7CDKN1A, TP53
10epidermal growth factor receptor signaling pathwayGO:0071739.7ERBB2, CDKN1A, EGFR, FGF3
11neurotrophin TRK receptor signaling pathwayGO:0480119.7ERBB2, CDKN1A, EGFR, FGF3
12Notch signaling pathwayGO:0072199.6TP53, NOTCH1, RBX1
13signal transductionGO:0071659.1NR2F1, ERBB2, EGFR, CGB, FGF3

Molecular functions related to Transitional Cell Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1epidermal growth factor-activated receptor activityGO:00500610.1EGFR, ERBB2
2transmembrane receptor protein tyrosine kinase activityGO:00471410.0EGFR, ERBB2
3receptor signaling protein tyrosine kinase activityGO:0047169.9ERBB2, EGFR
4protein phosphatase bindingGO:0199039.8EGFR, ERBB2, TP53
5protein bindingGO:0055156.7MZF1, TP53, PRSS8, NR2F1, ERBB2, NOTCH1

Products for genes affiliated with Transitional Cell Carcinoma

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Transitional Cell Carcinoma

About this section
4CDC
14ExPASy
15FMA
23GTR
24HGMD
25HMDB
26ICD10
27ICD10 via Orphanet
28ICD9CM
30IUPHAR
31KEGG
36MeSH
37MESH via Orphanet
38MGI
41NCIt
42NDF-RT
45NINDS
46Novoseek
48OMIM
49OMIM via Orphanet
53PubMed
54QIAGEN
60SNOMED-CT via Orphanet
63UMLS
64UMLS via Orphanet